Research map: The Impact of the G8 Score on Survival Outcomes in Patients With Head and Neck Cancer Undergoing Concurrent Radiotherapy With Cetuximab due to Contraindications With Cisplatin

Back to the article

Papers in this map

  1. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck · James A. Bonner · 2006 · 5136 citations · Cited by this paper
  2. Association of the Affordable Care Act With Receipt of Guideline‐Concordant Adjuvant Chemotherapy for Colon and Non‐Small Cell Lung Cancer · 2026 · Related
  3. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients · Jean‐Pierre Pignon · 2009 · 3083 citations · Cited by this paper
  4. Predicting Poor Efficacy of Cabozantinib in Advanced Renal Cell Carcinoma by Exploratory Metabolic Pathway Analysis and In Vitro Verification · 2026 · Related
  5. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer · David J. Adelstein · 2002 · 1760 citations · Cited by this paper
  6. Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis · 2026 · Related
  7. Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis · Mitchell X. Machtay · 2008 · 1380 citations · Cited by this paper
  8. The Zuo Jin Wan Formula Reverses Cisplatin Resistance in Gastric Cancer by Inhibiting the Mitochondrial Translocation of Dynamin‐Related Protein 1 and Its Mediated Mitochondrial Fission and Mitophagy · 2026 · Related
  9. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool · Carine A. Bellera · 2012 · 1131 citations · Cited by this paper
  10. Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA ‐Dependent Tumor Immune Microenvironment · 2026 · Related
  11. Final Results of the 94–01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial Comparing Radiotherapy Alone With Concomitant Radiochemotherapy in Advanced-Stage Oropharynx Carcinoma · Fabrice Denis · 2003 · 902 citations · Cited by this paper
  12. Overcoming Radiation Resistance: Ferroptosis Induction to Sensitize Solid Tumors to Radiation Therapy · 2026 · Related
  13. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations · Lore Decoster · 2014 · 796 citations · Cited by this paper
  14. Inhibition of the Metalloproteinase ADAMTS5 Suppresses Colorectal Cancer Metastasis via the PEDF /Wnt/β‐Catenin Pathway · 2026 · Related
  15. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site · Pierre Blanchard · 2011 · 628 citations · Cited by this paper
  16. Machine Learning for Prediction of High‐Risk Infections in Patients With Cancer · 2026 · Related
  17. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002) · Sue S. Yom · 2021 · 386 citations · Cited by this paper
  18. Watch and Wait Strategy for Locally Advanced Rectal Cancer: Update From Results of Recent Clinical Trials · 2026 · Related
  19. Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy · P Huguenin · 2004 · 262 citations · Cited by this paper
  20. Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial · Yungan Tao · 2022 · 192 citations · Cited by this paper
  21. ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer · Maria Gebre‐Medhin · 2020 · 183 citations · Cited by this paper
  22. Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study · Danny Rischin · 2021 · 157 citations · Cited by this paper
  23. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study? · Sabine Stordeur · 2020 · 47 citations · Cited by this paper
  24. The Impact of Comorbidity on Survival in Patients With Head and Neck Squamous Cell Carcinoma: A Nationwide Case-Control Study Spanning 35 Years · Eva Kristine Ruud Kjær · 2021 · 47 citations · Cited by this paper
  25. Use of the Geriatric-8 screening tool to predict prognosis and complications in older adults with head and neck cancer: A prospective, observational study · Ryo Ishii · 2021 · 47 citations · Cited by this paper
  26. Current Management of Locally Advanced Head and Neck Cancer: The Combination of Chemotherapy With Locoregional Treatments · Voichita Bar‐Ad · 2014 · 43 citations · Cited by this paper
  27. Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer · Lova Sun · 2022 · 42 citations · Cited by this paper
  28. Cetuximab is Effective, but more Toxic than Reported in the Bonner Trial · H. Lord · 2007 · 30 citations · Cited by this paper
  29. Comparison of Comorbidity and Frailty Indices in Patients With Head and Neck Cancer Using an Online Tool · Lucas Kas Vitzthum · 2018 · 28 citations · Cited by this paper
  30. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer · Jimmy J. Caudell · 2022 · 24 citations · Cited by this paper
  31. Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD) · David J Thomson · 2023 · 24 citations · Cited by this paper
  32. A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma · Mete Gündoğ · 2019 · 19 citations · Cited by this paper
  33. Editorial comment: Ratios should be multiplied, not added · J. André Knottnerus · 2016 · 10 citations · Cited by this paper
  34. Impact of stereotactic body radiation therapy on geriatric assessment and management for older patients with head and neck cancer using G8 · Emile Gogineni · 2020 · 9 citations · Cited by this paper
  35. Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH) · Yungan Tao · 2019 · 6 citations · Cited by this paper
  36. Prognostic performance of the modified-G8 screening instrument for patients aged 60 years or older: A prospective cohort of 889 Brazilian patients · Davi Brito Camara · 2019 · 5 citations · Cited by this paper
  37. Impaired geriatric 8 score is associated with worse survival after radical intensity modulated radiation therapy in elderly patients with nasopharyngeal carcinoma · Zhaohui Liao · 2023 · 4 citations · Cited by this paper
  38. Managing Patients with Head and Neck Cancer and Advanced Age or Comorbidities · James Price · 2025 · 4 citations · Cited by this paper
  39. Untitled · Cited by this paper

Source: OpenAlex (CC0)